FDA expands Merck’s Ebola vaccine approval to children one year and older

The first FDA-approved Ebola vaccine, dubbed Ervebo, is now available to children as young as one year old, Merck announced today. The approval expands on a 2019 approval of the vaccine for adults.

Europe is also likely on its way to an expanded approval of the vaccine after the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended it, with a final decision expected this quarter.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

Opinion | The Sackler Family Can Act Today to Compensate Opioid Overdose Victims

LaBelle is an expert in addiction policy and drug control law. Fields is a legal fellow. In March 2022, three members of the Sackler family

January 15, 2024

Xenotransplantation model used for studying microglial response to Alzheimer’s disease

Microglia are specialized immune cells in the brain. While they normally protect our brains, they can also contribute to neurodegenerative diseases such as Alzheimer’s.

March 27, 2024

Cardiometabolic Disorders Tend to Accompany a ‘Lazy Eye’

Somehow, people with persistent amblyopia (also known as “lazy eye”) from childhood had a higher risk of cardiometabolic disorders in adulthood, an observational cohort study

March 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.